stockportfolio.pro
Stocks / RVTY vs SMMT
RVTY vs SMMT
Revvity, Inc. and Summit Therapeutics Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
RVTY is the larger company ($10.9B vs $10.4B). On the fundamentals, RVTY has the stronger return on equity (3.3% vs -163.9%). Full numbers below — the stronger figure on each row is in green.
| Revvity, Inc. (RVTY) | Summit Therapeutics Inc. (SMMT) | |
|---|---|---|
| Market cap | $10.9B | $10.4B |
| Revenue (latest FY) | $2.86B | $0 |
| Net income (latest FY) | $241.20M | $-1.08B |
| Revenue growth (5y CAGR) | -5.5% | — |
| Net margin | 8.4% | — |
| Return on equity | 3.3% | -163.9% |
| P/E ratio | 47.0 | — |
| Dividend yield | 0.3% | — |
| Profitable years (of last 10) | 10 | 1 |
| Positive free cash flow | Yes | No |
Compare with another company:
See the full RVTY vs SMMT breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open RVTY's full financials → Open SMMT's full financials →More comparisons
Frequently asked questions
Which is bigger, RVTY or SMMT?
Revvity, Inc. is larger by market capitalization — $10.9B versus $10.4B.
Which grows faster, RVTY or SMMT?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.